Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses the use of the drug ivermectin to treat Covid-19. Bloomberg Businessweek Editor Joel Weber shares stories from the new issue of Businessweek Magazine. Axel Hefer, CEO at Trivago, talks about the company's earnings and how new global virus cases are impacting the travel industry. And we Drive to the Close with Jay Hatfield, CEO at Infrastructure Capital Advisors.

Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses the use of the drug ivermectin to treat Covid-19. Bloomberg Businessweek Editor Joel Weber shares stories from the new issue of Businessweek Magazine. Axel Hefer, CEO at Trivago, talks about the company's earnings and how new global virus cases are impacting the travel industry. And we Drive to the Close with Jay Hatfield, CEO at Infrastructure Capital Advisors.Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Travel Rebound Hindered by Delta Variant

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/3a4f1d7e-f4aa-4d20-a94d-ae2b002baf72/transcript

Advertisement